Viewing Study NCT07044050


Ignite Creation Date: 2025-12-24 @ 4:52 PM
Ignite Modification Date: 2026-03-05 @ 10:31 PM
Study NCT ID: NCT07044050
Status: RECRUITING
Last Update Posted: 2025-06-29
First Post: 2025-06-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A First-in-human Study to Assess OT-C001 (Amplified/Activated Allogenic Natural Killer Cells) in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma
Sponsor: Emercell SAS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module